BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain
Stopped after original approval, IRB closed enrollment; major revisions required to re-open.
Conditions
- Brain and Central Nervous System Tumors
- Breast Cancer
- Cognitive/Functional Effects
- Drug/Agent Toxicity by Tissue/Organ
- Psychosocial Effects of Cancer and Its Treatment
Interventions
- BIOLOGICAL: trastuzumab
- DRUG: carboplatin
- DRUG: methotrexate
- DRUG: sodium thiosulfate
Sponsor
OHSU Knight Cancer Institute
Collaborators